Arylpiperazines and their use as metalloproteinase inhibiting agents (MMP)
US6734184B1 · kind B1 · utility
13Cited by
10References
14Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Feb 26, 2001 |
| Grant date | May 11, 2004 |
| Priority date | — |
| Expiry date | Feb 26, 2021 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07D417/12
- WIPO fieldOrganic fine chemistry
- WIPO sectorChemistry
Abstract
Arylpiperazines of formula (I) useful as metalloproteinase inhibitors, especially as inhibitors of MMP 13.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.